What's the best modality for patient selection for predicting response to PD-1/PD-L1 inhibitors?
Sign Up to like & getrecommendations! Published in 2020 at "Translational lung cancer research"
DOI: 10.21037/tlcr.2019.12.06
Abstract: Lu S and colleagues made an exhaustive comparison of several biomarker modalities for predicting response to PD-1/PD-L1 checkpoint blockade (1). The type of test impacts patient’s response to therapy and varies according to the country… read more here.
Keywords: predicting response; best modality; use; response ... See more keywords